[{"Assets_0_Q2_USD":79357000.0,"CommonStockSharesOutstanding_0_Q2_shares":164122.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-15687000.0,"NetIncomeLoss_1_Q2_USD":-15140000.0,"NetIncomeLoss_2_Q2_USD":-27145000.0,"StockholdersEquity_0_Q2_USD":-46989000.0,"Ticker":"KRTX","CIK":"1771917","name":"KARUNA THERAPEUTICS, INC.","OfficialName":"Karuna Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3925750608.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]